High-dose chemotherapy in patients with breast cancer: evaluation of infusing peripheral blood stem cells containing occult tumor cells

An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy

C H Weaver, B Hazelton, Robert Birch et al. · Blood · 1995 · 621 citations · Full text

Medicine, Cell Biology, Hematology +17

Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma

RJ Berenson, R.S. Hill, RG Andrews et al. · Blood · 1991 · 522 citations · Full text

Medicine, Cell Biology, Oncology +13

Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML

AB Deisseroth, Z. Zu, David F. Claxton et al. · Blood · 1994 · 484 citations · Full text

Medicine, Genetics, Hematology +17

Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [see comments]

AA Ross, BW Cooper, H M Lazarus et al. · Blood · 1993 · 455 citations · Full text

Medicine, Cell Biology, Oncology +17

Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.

R. J. Cote, Paul Peter Rosen, Martin Lesser et al. · Journal of Clinical Oncology · 1991 · 443 citations

Medicine, Oncology, Pathology +16